English
简体中文
Total: £ 56.28
Published Date: 2026-03-02 | Pages: 124 | Tables: 125 | Medical Care
The global Chinese Patent Medicine for Bones and Muscles market was valued at US$ 3202 million in 2025 and is anticipated to reach US$ 4520 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Chinese patent medicine are herbal medicines in Traditional Chinese medicine, modernized into a ready-to-use form such as tablets, oral solutions or dry suspensions, as opposed to herbs that require cooking (hot water extraction). This report focus on Chinese Patent Medicine for Bones and Muscles.
As an indispensable part of Traditional Chinese medicine (TCM), Chinese patent medicines have played an important role in preventing and treating diseases in China. Since they are easy to use, easy to store, and cost-effective, Chinese patent medicines have been generally accepted and widely used in Chinese clinical practice as a vital medical resource. In recent years, as TCM has developed and it has been accepted around the world, many Chinese patent medicine companies have gained international market access and successfully registered several Chinese patent medicines as over-the-counter (OTC) or prescription drugs in regions and countries that primarily use Western medicine such as the EU, Russia, Canada, Singapore, and Vietnam. Moreover, several Chinese patent medicines have been obtained the US Food and Drug Administration (FDA) approval conducting phase II or III clinical trials in the US.
This report delivers a comprehensive overview of the global Chinese Patent Medicine for Bones and Muscles market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Chinese Patent Medicine for Bones and Muscles. The Chinese Patent Medicine for Bones and Muscles market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Chinese Patent Medicine for Bones and Muscles market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Chinese Patent Medicine for Bones and Muscles manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Zhongheng Group
Fangsheng Pharmaceutical
Yunnan Baiyao Group
Beijing TRT Group
Pien Tze Huang Pharmaceutical
BaiYunShan Pharmaceutical
China Resources Sanjiu
Yiling Pharmaceutical
Jumpcan Pharmaceutical
Tasly Group
Buchang Pharmaceutical
Sunflower Pharmaceutical
Ginwa Enterprise
KPC Pharmaceutical
Jiangsu Kanion Pharmaceutical
Xintian Pharmaceutical
Henan Lingrui Pharmaceutical
Segment by Type
Oral
Topical
Others
Segment by Application
Hospital
Pharmacy
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Chinese Patent Medicine for Bones and Muscles companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chinese Patent Medicine for Bones and Muscles Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Oral
1.2.3 Topical
1.2.4 Others
1.3 Market by Application
1.3.1 Global Chinese Patent Medicine for Bones and Muscles Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chinese Patent Medicine for Bones and Muscles Market Perspective (2021–2032)
2.2 Global Chinese Patent Medicine for Bones and Muscles Growth Trends by Region
2.2.1 Global Chinese Patent Medicine for Bones and Muscles Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Chinese Patent Medicine for Bones and Muscles Historic Market Size by Region (2021–2026)
2.2.3 Chinese Patent Medicine for Bones and Muscles Forecasted Market Size by Region (2027–2032)
2.3 Chinese Patent Medicine for Bones and Muscles Market Dynamics
2.3.1 Chinese Patent Medicine for Bones and Muscles Industry Trends
2.3.2 Chinese Patent Medicine for Bones and Muscles Market Drivers
2.3.3 Chinese Patent Medicine for Bones and Muscles Market Challenges
2.3.4 Chinese Patent Medicine for Bones and Muscles Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chinese Patent Medicine for Bones and Muscles Players by Revenue
3.1.1 Global Top Chinese Patent Medicine for Bones and Muscles Players by Revenue (2021–2026)
3.1.2 Global Chinese Patent Medicine for Bones and Muscles Revenue Market Share by Players (2021–2026)
3.2 Global Top Chinese Patent Medicine for Bones and Muscles Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Chinese Patent Medicine for Bones and Muscles Revenue
3.4 Global Chinese Patent Medicine for Bones and Muscles Market Concentration Ratio
3.4.1 Global Chinese Patent Medicine for Bones and Muscles Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chinese Patent Medicine for Bones and Muscles Revenue in 2025
3.5 Global Key Players of Chinese Patent Medicine for Bones and Muscles Head Offices and Areas Served
3.6 Global Key Players of Chinese Patent Medicine for Bones and Muscles, Products and Applications
3.7 Global Key Players of Chinese Patent Medicine for Bones and Muscles, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Chinese Patent Medicine for Bones and Muscles Breakdown Data by Type
4.1 Global Chinese Patent Medicine for Bones and Muscles Historic Market Size by Type (2021–2026)
4.2 Global Chinese Patent Medicine for Bones and Muscles Forecasted Market Size by Type (2027–2032)
5 Chinese Patent Medicine for Bones and Muscles Breakdown Data by Application
5.1 Global Chinese Patent Medicine for Bones and Muscles Historic Market Size by Application (2021–2026)
5.2 Global Chinese Patent Medicine for Bones and Muscles Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Chinese Patent Medicine for Bones and Muscles Market Size (2021–2032)
6.2 North America Chinese Patent Medicine for Bones and Muscles Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Chinese Patent Medicine for Bones and Muscles Market Size by Country (2021–2026)
6.4 North America Chinese Patent Medicine for Bones and Muscles Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chinese Patent Medicine for Bones and Muscles Market Size (2021–2032)
7.2 Europe Chinese Patent Medicine for Bones and Muscles Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Chinese Patent Medicine for Bones and Muscles Market Size by Country (2021–2026)
7.4 Europe Chinese Patent Medicine for Bones and Muscles Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Size (2021–2032)
8.2 Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Size by Region (2021–2026)
8.4 Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Chinese Patent Medicine for Bones and Muscles Market Size (2021–2032)
9.2 Latin America Chinese Patent Medicine for Bones and Muscles Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Chinese Patent Medicine for Bones and Muscles Market Size by Country (2021–2026)
9.4 Latin America Chinese Patent Medicine for Bones and Muscles Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Size (2021–2032)
10.2 Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Size by Country (2021–2026)
10.4 Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zhongheng Group
11.1.1 Zhongheng Group Company Details
11.1.2 Zhongheng Group Business Overview
11.1.3 Zhongheng Group Chinese Patent Medicine for Bones and Muscles Introduction
11.1.4 Zhongheng Group Revenue in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
11.1.5 Zhongheng Group Recent Development
11.2 Fangsheng Pharmaceutical
11.2.1 Fangsheng Pharmaceutical Company Details
11.2.2 Fangsheng Pharmaceutical Business Overview
11.2.3 Fangsheng Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction
11.2.4 Fangsheng Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
11.2.5 Fangsheng Pharmaceutical Recent Development
11.3 Yunnan Baiyao Group
11.3.1 Yunnan Baiyao Group Company Details
11.3.2 Yunnan Baiyao Group Business Overview
11.3.3 Yunnan Baiyao Group Chinese Patent Medicine for Bones and Muscles Introduction
11.3.4 Yunnan Baiyao Group Revenue in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
11.3.5 Yunnan Baiyao Group Recent Development
11.4 Beijing TRT Group
11.4.1 Beijing TRT Group Company Details
11.4.2 Beijing TRT Group Business Overview
11.4.3 Beijing TRT Group Chinese Patent Medicine for Bones and Muscles Introduction
11.4.4 Beijing TRT Group Revenue in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
11.4.5 Beijing TRT Group Recent Development
11.5 Pien Tze Huang Pharmaceutical
11.5.1 Pien Tze Huang Pharmaceutical Company Details
11.5.2 Pien Tze Huang Pharmaceutical Business Overview
11.5.3 Pien Tze Huang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction
11.5.4 Pien Tze Huang Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
11.5.5 Pien Tze Huang Pharmaceutical Recent Development
11.6 BaiYunShan Pharmaceutical
11.6.1 BaiYunShan Pharmaceutical Company Details
11.6.2 BaiYunShan Pharmaceutical Business Overview
11.6.3 BaiYunShan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction
11.6.4 BaiYunShan Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
11.6.5 BaiYunShan Pharmaceutical Recent Development
11.7 China Resources Sanjiu
11.7.1 China Resources Sanjiu Company Details
11.7.2 China Resources Sanjiu Business Overview
11.7.3 China Resources Sanjiu Chinese Patent Medicine for Bones and Muscles Introduction
11.7.4 China Resources Sanjiu Revenue in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
11.7.5 China Resources Sanjiu Recent Development
11.8 Yiling Pharmaceutical
11.8.1 Yiling Pharmaceutical Company Details
11.8.2 Yiling Pharmaceutical Business Overview
11.8.3 Yiling Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction
11.8.4 Yiling Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
11.8.5 Yiling Pharmaceutical Recent Development
11.9 Jumpcan Pharmaceutical
11.9.1 Jumpcan Pharmaceutical Company Details
11.9.2 Jumpcan Pharmaceutical Business Overview
11.9.3 Jumpcan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction
11.9.4 Jumpcan Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
11.9.5 Jumpcan Pharmaceutical Recent Development
11.10 Tasly Group
11.10.1 Tasly Group Company Details
11.10.2 Tasly Group Business Overview
11.10.3 Tasly Group Chinese Patent Medicine for Bones and Muscles Introduction
11.10.4 Tasly Group Revenue in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
11.10.5 Tasly Group Recent Development
11.11 Buchang Pharmaceutical
11.11.1 Buchang Pharmaceutical Company Details
11.11.2 Buchang Pharmaceutical Business Overview
11.11.3 Buchang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction
11.11.4 Buchang Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
11.11.5 Buchang Pharmaceutical Recent Development
11.12 Sunflower Pharmaceutical
11.12.1 Sunflower Pharmaceutical Company Details
11.12.2 Sunflower Pharmaceutical Business Overview
11.12.3 Sunflower Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction
11.12.4 Sunflower Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
11.12.5 Sunflower Pharmaceutical Recent Development
11.13 Ginwa Enterprise
11.13.1 Ginwa Enterprise Company Details
11.13.2 Ginwa Enterprise Business Overview
11.13.3 Ginwa Enterprise Chinese Patent Medicine for Bones and Muscles Introduction
11.13.4 Ginwa Enterprise Revenue in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
11.13.5 Ginwa Enterprise Recent Development
11.14 KPC Pharmaceutical
11.14.1 KPC Pharmaceutical Company Details
11.14.2 KPC Pharmaceutical Business Overview
11.14.3 KPC Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction
11.14.4 KPC Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
11.14.5 KPC Pharmaceutical Recent Development
11.15 Jiangsu Kanion Pharmaceutical
11.15.1 Jiangsu Kanion Pharmaceutical Company Details
11.15.2 Jiangsu Kanion Pharmaceutical Business Overview
11.15.3 Jiangsu Kanion Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction
11.15.4 Jiangsu Kanion Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
11.15.5 Jiangsu Kanion Pharmaceutical Recent Development
11.16 Xintian Pharmaceutical
11.16.1 Xintian Pharmaceutical Company Details
11.16.2 Xintian Pharmaceutical Business Overview
11.16.3 Xintian Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction
11.16.4 Xintian Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
11.16.5 Xintian Pharmaceutical Recent Development
11.17 Henan Lingrui Pharmaceutical
11.17.1 Henan Lingrui Pharmaceutical Company Details
11.17.2 Henan Lingrui Pharmaceutical Business Overview
11.17.3 Henan Lingrui Pharmaceutical Chinese Patent Medicine for Bones and Muscles Introduction
11.17.4 Henan Lingrui Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
11.17.5 Henan Lingrui Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Chinese Patent Medicine for Bones and Muscles Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Oral
Table 3. Key Players of Topical
Table 4. Key Players of Others
Table 5. Global Chinese Patent Medicine for Bones and Muscles Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Chinese Patent Medicine for Bones and Muscles Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Chinese Patent Medicine for Bones and Muscles Market Size by Region (US$ Million), 2021–2026
Table 8. Global Chinese Patent Medicine for Bones and Muscles Market Share by Region (2021–2026)
Table 9. Global Chinese Patent Medicine for Bones and Muscles Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Chinese Patent Medicine for Bones and Muscles Market Share by Region (2027–2032)
Table 11. Chinese Patent Medicine for Bones and Muscles Market Trends
Table 12. Chinese Patent Medicine for Bones and Muscles Market Drivers
Table 13. Chinese Patent Medicine for Bones and Muscles Market Challenges
Table 14. Chinese Patent Medicine for Bones and Muscles Market Restraints
Table 15. Global Chinese Patent Medicine for Bones and Muscles Revenue by Players (US$ Million), 2021–2026
Table 16. Global Chinese Patent Medicine for Bones and Muscles Market Share by Players (2021–2026)
Table 17. Global Top Chinese Patent Medicine for Bones and Muscles Players by Tier (Tier 1, Tier 2, and Tier 3), based on Chinese Patent Medicine for Bones and Muscles Revenue, 2025
Table 18. Ranking of Global Top Chinese Patent Medicine for Bones and Muscles Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Chinese Patent Medicine for Bones and Muscles Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Chinese Patent Medicine for Bones and Muscles, Headquarters and Area Served
Table 21. Global Key Players of Chinese Patent Medicine for Bones and Muscles, Products and Applications
Table 22. Global Key Players of Chinese Patent Medicine for Bones and Muscles, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Chinese Patent Medicine for Bones and Muscles Market Size by Type (US$ Million), 2021–2026
Table 25. Global Chinese Patent Medicine for Bones and Muscles Revenue Market Share by Type (2021–2026)
Table 26. Global Chinese Patent Medicine for Bones and Muscles Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Chinese Patent Medicine for Bones and Muscles Revenue Market Share by Type (2027–2032)
Table 28. Global Chinese Patent Medicine for Bones and Muscles Market Size by Application (US$ Million), 2021–2026
Table 29. Global Chinese Patent Medicine for Bones and Muscles Revenue Market Share by Application (2021–2026)
Table 30. Global Chinese Patent Medicine for Bones and Muscles Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Chinese Patent Medicine for Bones and Muscles Revenue Market Share by Application (2027–2032)
Table 32. North America Chinese Patent Medicine for Bones and Muscles Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Chinese Patent Medicine for Bones and Muscles Market Size by Country (US$ Million), 2021–2026
Table 34. North America Chinese Patent Medicine for Bones and Muscles Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Chinese Patent Medicine for Bones and Muscles Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Chinese Patent Medicine for Bones and Muscles Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Chinese Patent Medicine for Bones and Muscles Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Chinese Patent Medicine for Bones and Muscles Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Chinese Patent Medicine for Bones and Muscles Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Chinese Patent Medicine for Bones and Muscles Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Size by Country (US$ Million), 2027–2032
Table 47. Zhongheng Group Company Details
Table 48. Zhongheng Group Business Overview
Table 49. Zhongheng Group Chinese Patent Medicine for Bones and Muscles Product
Table 50. Zhongheng Group Revenue in Chinese Patent Medicine for Bones and Muscles Business (US$ Million), 2021–2026
Table 51. Zhongheng Group Recent Development
Table 52. Fangsheng Pharmaceutical Company Details
Table 53. Fangsheng Pharmaceutical Business Overview
Table 54. Fangsheng Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product
Table 55. Fangsheng Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (US$ Million), 2021–2026
Table 56. Fangsheng Pharmaceutical Recent Development
Table 57. Yunnan Baiyao Group Company Details
Table 58. Yunnan Baiyao Group Business Overview
Table 59. Yunnan Baiyao Group Chinese Patent Medicine for Bones and Muscles Product
Table 60. Yunnan Baiyao Group Revenue in Chinese Patent Medicine for Bones and Muscles Business (US$ Million), 2021–2026
Table 61. Yunnan Baiyao Group Recent Development
Table 62. Beijing TRT Group Company Details
Table 63. Beijing TRT Group Business Overview
Table 64. Beijing TRT Group Chinese Patent Medicine for Bones and Muscles Product
Table 65. Beijing TRT Group Revenue in Chinese Patent Medicine for Bones and Muscles Business (US$ Million), 2021–2026
Table 66. Beijing TRT Group Recent Development
Table 67. Pien Tze Huang Pharmaceutical Company Details
Table 68. Pien Tze Huang Pharmaceutical Business Overview
Table 69. Pien Tze Huang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product
Table 70. Pien Tze Huang Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (US$ Million), 2021–2026
Table 71. Pien Tze Huang Pharmaceutical Recent Development
Table 72. BaiYunShan Pharmaceutical Company Details
Table 73. BaiYunShan Pharmaceutical Business Overview
Table 74. BaiYunShan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product
Table 75. BaiYunShan Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (US$ Million), 2021–2026
Table 76. BaiYunShan Pharmaceutical Recent Development
Table 77. China Resources Sanjiu Company Details
Table 78. China Resources Sanjiu Business Overview
Table 79. China Resources Sanjiu Chinese Patent Medicine for Bones and Muscles Product
Table 80. China Resources Sanjiu Revenue in Chinese Patent Medicine for Bones and Muscles Business (US$ Million), 2021–2026
Table 81. China Resources Sanjiu Recent Development
Table 82. Yiling Pharmaceutical Company Details
Table 83. Yiling Pharmaceutical Business Overview
Table 84. Yiling Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product
Table 85. Yiling Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (US$ Million), 2021–2026
Table 86. Yiling Pharmaceutical Recent Development
Table 87. Jumpcan Pharmaceutical Company Details
Table 88. Jumpcan Pharmaceutical Business Overview
Table 89. Jumpcan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product
Table 90. Jumpcan Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (US$ Million), 2021–2026
Table 91. Jumpcan Pharmaceutical Recent Development
Table 92. Tasly Group Company Details
Table 93. Tasly Group Business Overview
Table 94. Tasly Group Chinese Patent Medicine for Bones and Muscles Product
Table 95. Tasly Group Revenue in Chinese Patent Medicine for Bones and Muscles Business (US$ Million), 2021–2026
Table 96. Tasly Group Recent Development
Table 97. Buchang Pharmaceutical Company Details
Table 98. Buchang Pharmaceutical Business Overview
Table 99. Buchang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product
Table 100. Buchang Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (US$ Million), 2021–2026
Table 101. Buchang Pharmaceutical Recent Development
Table 102. Sunflower Pharmaceutical Company Details
Table 103. Sunflower Pharmaceutical Business Overview
Table 104. Sunflower Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product
Table 105. Sunflower Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (US$ Million), 2021–2026
Table 106. Sunflower Pharmaceutical Recent Development
Table 107. Ginwa Enterprise Company Details
Table 108. Ginwa Enterprise Business Overview
Table 109. Ginwa Enterprise Chinese Patent Medicine for Bones and Muscles Product
Table 110. Ginwa Enterprise Revenue in Chinese Patent Medicine for Bones and Muscles Business (US$ Million), 2021–2026
Table 111. Ginwa Enterprise Recent Development
Table 112. KPC Pharmaceutical Company Details
Table 113. KPC Pharmaceutical Business Overview
Table 114. KPC Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product
Table 115. KPC Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (US$ Million), 2021–2026
Table 116. KPC Pharmaceutical Recent Development
Table 117. Jiangsu Kanion Pharmaceutical Company Details
Table 118. Jiangsu Kanion Pharmaceutical Business Overview
Table 119. Jiangsu Kanion Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product
Table 120. Jiangsu Kanion Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (US$ Million), 2021–2026
Table 121. Jiangsu Kanion Pharmaceutical Recent Development
Table 122. Xintian Pharmaceutical Company Details
Table 123. Xintian Pharmaceutical Business Overview
Table 124. Xintian Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product
Table 125. Xintian Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (US$ Million), 2021–2026
Table 126. Xintian Pharmaceutical Recent Development
Table 127. Henan Lingrui Pharmaceutical Company Details
Table 128. Henan Lingrui Pharmaceutical Business Overview
Table 129. Henan Lingrui Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product
Table 130. Henan Lingrui Pharmaceutical Revenue in Chinese Patent Medicine for Bones and Muscles Business (US$ Million), 2021–2026
Table 131. Henan Lingrui Pharmaceutical Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
Table 135. Authors List of This Report
List of Figures
Figure 1. Chinese Patent Medicine for Bones and Muscles Picture
Figure 2. Global Chinese Patent Medicine for Bones and Muscles Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Chinese Patent Medicine for Bones and Muscles Market Share by Type: 2025 vs 2032
Figure 4. Oral Features
Figure 5. Topical Features
Figure 6. Others Features
Figure 7. Global Chinese Patent Medicine for Bones and Muscles Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Chinese Patent Medicine for Bones and Muscles Market Share by Application: 2025 vs 2032
Figure 9. Hospital Case Studies
Figure 10. Pharmacy Case Studies
Figure 11. Others Case Studies
Figure 12. Chinese Patent Medicine for Bones and Muscles Report Years Considered
Figure 13. Global Chinese Patent Medicine for Bones and Muscles Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Chinese Patent Medicine for Bones and Muscles Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Chinese Patent Medicine for Bones and Muscles Market Share by Region: 2025 vs 2032
Figure 16. Global Chinese Patent Medicine for Bones and Muscles Market Share by Players in 2025
Figure 17. Global Chinese Patent Medicine for Bones and Muscles Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Chinese Patent Medicine for Bones and Muscles Revenue in 2025
Figure 19. North America Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Chinese Patent Medicine for Bones and Muscles Market Share by Country (2021–2032)
Figure 21. United States Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Chinese Patent Medicine for Bones and Muscles Market Share by Country (2021–2032)
Figure 25. Germany Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Share by Region (2021–2032)
Figure 33. China Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Chinese Patent Medicine for Bones and Muscles Market Share by Country (2021–2032)
Figure 41. Mexico Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Share by Country (2021–2032)
Figure 45. Israel Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Chinese Patent Medicine for Bones and Muscles Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Zhongheng Group Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
Figure 49. Fangsheng Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
Figure 50. Yunnan Baiyao Group Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
Figure 51. Beijing TRT Group Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
Figure 52. Pien Tze Huang Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
Figure 53. BaiYunShan Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
Figure 54. China Resources Sanjiu Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
Figure 55. Yiling Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
Figure 56. Jumpcan Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
Figure 57. Tasly Group Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
Figure 58. Buchang Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
Figure 59. Sunflower Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
Figure 60. Ginwa Enterprise Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
Figure 61. KPC Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
Figure 62. Jiangsu Kanion Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
Figure 63. Xintian Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
Figure 64. Henan Lingrui Pharmaceutical Revenue Growth Rate in Chinese Patent Medicine for Bones and Muscles Business (2021–2026)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
